Related Experiment Video
Updated: Jun 16, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
LysJEP8: A promising novel endolysin for combating multidrug-resistant Gram-negative bacteria
Jose Vicente Carratalá1,2,3,4, Neus Ferrer-Miralles1,2,4, Elena Garcia-Fruitós3
1Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona, Barcelona, Spain.
Abstract:
Antimicrobial resistance (AMR) is an escalating global health crisis, driven by the overuse and misuse of antibiotics. Multidrug-resistant Gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, are particularly concerning due to their high morbidity and mortality rates. In this context, endolysins, derived from bacteriophages, offer a promising alternative to traditional antibiotics. This study introduces LysJEP8, a novel endolysin derived from Escherichia phage JEP8, which exhibits remarkable antimicrobial activity against key Gram-negative members of the ESKAPE group. Comparative assessments highlight LysJEP8's superior performance in reducing bacterial survival rates compared to previously described endolysins, with the most significant impact observed against P. aeruginosa, and notable effects on A. baumannii and K. pneumoniae. The study found that LysJEP8, as predicted by in silico analysis, worked best at lower pH values but lost its effectiveness at salt concentrations close to physiological levels. Importantly, LysJEP8 exhibited remarkable efficacy in the disruption of P. aeruginosa biofilms. This research underscores the potential of LysJEP8 as a valuable candidate for the development of innovative antibacterial agents, particularly against Gram-negative pathogens, and highlights opportunities for further engineering and optimization to address AMR effectively.
Insights
A new endolysin, LysJEP8, shows strong potential against multidrug-resistant Gram-negative bacteria like Pseudomonas aeruginosa. This bacteriophage-derived protein effectively reduces bacterial survival and disrupts biofilms, offering a promising alternative to combat antimicrobial resistance.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a critical global health threat, exacerbated by antibiotic overuse.
- Multidrug-resistant Gram-negative bacteria, including ESKAPE pathogens, pose significant challenges due to high mortality rates.
- Bacteriophage-derived endolysins represent a novel therapeutic avenue against resistant bacteria.
Purpose of the Study:
- To introduce and characterize LysJEP8, a novel endolysin from Escherichia phage JEP8.
- To evaluate LysJEP8's antimicrobial activity against key Gram-negative pathogens.
- To assess LysJEP8's efficacy in combating bacterial biofilms.
Main Methods:
- In silico analysis to predict optimal activity conditions.
- Comparative assessment of LysJEP8's efficacy against ESKAPE pathogens.
- Evaluation of LysJEP8's performance at varying pH and salt concentrations.
- Assessment of LysJEP8's biofilm disruption capabilities.
Main Results:
- LysJEP8 demonstrated significant antimicrobial activity against Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.
- The endolysin showed superior bacterial reduction compared to other known endolysins, particularly against P. aeruginosa.
- Optimal activity was observed at lower pH, with reduced efficacy at physiological salt concentrations.
- LysJEP8 effectively disrupted P. aeruginosa biofilms.
Conclusions:
- LysJEP8 is a potent candidate for developing new antibacterial agents against Gram-negative pathogens.
- Further engineering of LysJEP8 could enhance its therapeutic potential in combating AMR.
- This endolysin offers a promising alternative to conventional antibiotics for treating resistant infections.
More Related Videos
Related Concept Videos
Formation of Lipopolysaccharides
Gram-negative Bacterial Protein Secretion Systems
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

